CD
Codexis, Inc.
CDXS · NASDAQ
$1.36 +0.74% (+$0.01)
1M -16.46%
Market Cap $152.7M
P/E Ratio -
Div. Yield -
ROE 74.36%
Piotroski F-Score Weak
3/9Valuation
59 /100
Fair P/B 4.63x
P/S 1.97x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 29.60%
Rev. growth 20.22%
FCF growth N/A
Profitability
20 /100
Weak Net margin 39.55%
Op. margin 31.23%
FCF margin 15.68%
Quality
8 /100
Poor ROE 74.36%
ROA 25.59%
Asset turnover 0.65x
Debt
29 /100
High Current ratio 3.06x
Int. coverage -22.72x
Debt/Equity 2.20x
Stability
7 /100
Unstable Rev. volatility 34.00%
EPS volatility 88.40%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o CDXS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alison Moore
Employees
146
Headquarters
Redwood City
Nadchodzące wydarzenia
05 LIS
Earnings
Upcoming earnings report